Drug Type Small molecule drug |
Synonyms VU0404251 |
Target |
Mechanism mGluR5 positive allosteric modulator(Metabotropic glutamate receptor 5 positive allosteric modulator) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H23FN2O2 |
InChIKeyVOYBJCDMLJODRK-CYBMUJFWSA-N |
CAS Registry1276013-77-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psychotic Disorders | Preclinical | US | 01 Oct 2012 |